RecruitingPhase 2NCT05607407

Methimazole in Patients With Progressive Glioblastoma

Studying Astrocytoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Case Comprehensive Cancer Center
Principal Investigator
David Peereboom, MD, MD
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Intervention
Methimazole(drug)
Enrollment
19 target
Eligibility
18 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05607407 on ClinicalTrials.gov

Other trials for Astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Astrocytoma →

← Back to all trials